رجوع
43
26
نطاق اليوم
KWD 71.00
KWD 71.00
نطاق 52 أسبوعًا
KWD 47.50
KWD 74.00
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 67.99
/
KWD 62.85
الإغلاق السابق
KWD 71.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 21.7 | 0.3 |
| P/B | 6.8 | 2.9 |
| ROE % | 38.5 | 3.7 |
| Net Margin % | 17.3 | 3.8 |
| Rev Growth 5Y % | 11.9 | 10.0 |
| D/E | 0.8 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
-KWD 0.372
-KWD 0.406 – -KWD 0.323
|
220 M | 1 |
| FY2028 |
KWD 0.895
KWD 0.775 – KWD 0.974
|
200 M | 1 |
| FY2027 |
KWD 4.672
KWD 4.049 – KWD 5.089
|
260 M | 1 |
النقاط الرئيسية
Revenue grew 11.93% annually over 5 years — strong growth
Earnings declined -48.17% over the past year
ROE of 38.49% indicates high profitability
Net margin of 17.30% shows strong profitability
Generating 59.50M in free cash flow
Cash machine — converts 147.94% of earnings into free cash flow
النمو
Revenue Growth (5Y)
11.93%
Revenue (1Y)11.49%
Earnings (1Y)-48.17%
FCF Growth (3Y)112.22%
الجودة
Return on Equity
38.49%
ROIC16.91%
Net Margin17.30%
Op. Margin22.20%
الأمان
Debt / Equity
0.79
Current Ratio5.11
Interest Coverage0.00
التقييم
P/E Ratio
21.66
P/B Ratio6.81
EV/EBITDA18.26
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.49% | Revenue Growth (3Y) | 21.45% |
| Earnings Growth (1Y) | -48.17% | Earnings Growth (3Y) | 96.17% |
| Revenue Growth (5Y) | 11.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 232.51M | Net Income (TTM) | 40.22M |
| ROE | 38.49% | ROA | 14.26% |
| Gross Margin | 83.09% | Operating Margin | 22.20% |
| Net Margin | 17.30% | Free Cash Flow (TTM) | 59.50M |
| ROIC | 16.91% | FCF Growth (3Y) | 112.22% |
| Safety | |||
| Debt / Equity | 0.79 | Current Ratio | 5.11 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 21.66 | P/B Ratio | 6.81 |
| P/S Ratio | 3.75 | PEG Ratio | -0.31 |
| EV/EBITDA | 18.26 | Dividend Yield | 0.00% |
| Market Cap | 871.33M | Enterprise Value | 942.65M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 232.51M | 208.54M | 157.63M | 147.77M | 148.12M |
| Net Income | 40.22M | 77.59M | 10.45M | 12.15M | -6.83M |
| EPS (Diluted) | 3.14 | 5.83 | 0.86 | 1.02 | -0.58 |
| Gross Profit | 193.19M | 169.86M | 130.84M | 123.16M | 124.05M |
| Operating Income | 51.62M | 61.18M | 19.21M | 18.54M | 1.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 282.13M | 257.76M | 173.29M | 220.85M | 247.27M |
| Total Liabilities | 154.13M | 176.77M | 183.29M | 265.86M | 305.87M |
| Shareholders' Equity | 128.00M | 81.00M | -10.00M | -45.01M | -58.61M |
| Total Debt | 100.98M | 111.67M | 128.61M | 187.14M | 218.96M |
| Cash & Equivalents | 29.66M | 120.70M | 59.90M | 84.70M | 53.70M |
| Current Assets | 251.85M | 220.91M | 152.15M | 175.36M | 241.07M |
| Current Liabilities | 49.24M | 45.56M | 47.59M | 74.85M | 174.41M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#565 of 1052
Custom
Capital Light Compounder
#175 of 218
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Capital Light Compounder
Mar 24, 2026